NCT06619353Active, not recruiting
RCVR (Residual CardioVascular Risk) Prospective Study
Residual CardioVascular Risk (RCVR) After Percutaneous Coronary Intervention: A Prospective Study
Source: ClinicalTrials.gov · Last updated 18 Feb 2026
Brief summary (registry, in English)
The goal of this observational study is to evaluate whether residual cardiovascular risk assessed at 1 month after percutaneous coronary intervention (PCI) is associated with long-term clinical outcomes in adult patients with coronary artery disease who are free from major adverse clinical events at 1 month after PCI. The main questions it aims to answer are: * Does residual cardiovascular risk at 1 month after PCI predict long-term net adverse clinical events? * Which components of residual cardiovascular risk are associated with subsequent adverse clinical outcomes? Participants will: * Undergo comprehensive laboratory testing at 1 month after PCI and annually thereafter. * Undergo artificial intelligence-based quantitative coronary angiographic analysis using DICOM datasets after PCI. * Be followed annually for up to 3 years after the 1-month assessment to evaluate clinical outcomes.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 500 (actual)
- First submitted
- 23 Sept 2024
- Start date
- 17 Jun 2024
- Primary completion date
- Feb 2029
- Lead sponsor
- CHA University
- Diseases
- Coronary artery disease
- NCT number
- NCT06619353
What you commit to
- Study type: Observational
- Participants enrolled: 500
- From 17 Jun 2024 to the primary completion date, Feb 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Currently has a malignancy or has a history of malignancy within the past 5 years.
- Occurrence of death, myocardial infarction, stroke, unplanned revascularization, or major bleeding within 1 month after the index PCI.
Age
- Under 19 years of age.
- Pregnant, breastfeeding, or women of childbearing age.
Other
- Life expectancy of less than 5 years.
- Inability or unwillingness to comply with scheduled follow-up assessments.
Who the study is looking for
- Patients who have undergone percutaneous coronary intervention.
- Patients who are free from death, myocardial infarction, stroke, unplanned revascularization, or major bleeding within 1 month after the index PCI.
- Patients who are able to undergo artificial intelligence-based quantitative coronary angiography using DICOM datasets.
- Patients who have provided written informed consent at the 1-month post-PCI visit.
Age in the registry: 20 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHA Bundang Medical Center Coordinator of this site? Confirm its status | Seongnam-si | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.